Bartonella henselae Antibody, IgM by IFA
Also known as: HENS M
Use
May assist in confirming an early or recent Bartonella henselae infection. The presence of IgM antibodies suggests recent infection, and low levels of these antibodies may occasionally persist for more than 12 months post infection.
Special Instructions
Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as 'acute' or 'convalescent'.
Limitations
This test was developed and its performance characteristics were determined by ARUP Laboratories but it has not been cleared or approved by the US Food and Drug Administration. As an analyte specific reagent (ASR), its use is intended for clinical purposes following laboratory validation studies in a CLIA-certified laboratory setting.
New York Approved
Methodology
Immunoassay (Other)
Biomarkers
LOINC Codes
- 6955-9
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.4 mL
Container
ARUP standard transport tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated
Causes for Rejection
Contaminated, hemolyzed, or severely lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |